24 Hours of Stem Cells

Over the past nine years, we have hosted over 325 leading scientific presentations at the Gibco virtual stem cell event–now 5 Days of Stem Cells. Below is a complete list of presentations and speakers since 2013 with select presentations available*.

Share your research with >4,000 researchers worldwide!

If you'd like to share your latest discoveries at this renowned virtual stem cell conference, contact the event coordinator at 5daysofstemcells@thermofisher.com.


Rapid dissociation of 3D spheroids using the Rotea Counterflow Centrifugation SystemMichael AkenheadThermo Fisher Scientific
Utilizing the Gibco™ CTS™ Rotea™ System, a versatile closed manufacturing system, for cell and gene therapy developmentEmily BenzViaCyte
A fateful decisionLaurie BoyerMassachusetts Institute of Technology
Development of humanized mouse models for biomedical researchMichael BrehmUniversity of Massachusetts Medical School
Beyond stem cells therapies: Mitochondria as a new living drug in regenerative medicineAndrés CaicedoUniversidad San Francisco de Quito
Maturation strategies for iPSC cardiac 3D tissues and phenotypic correction of calmodulinopathy disease models using CRISPRiHuang Chen-YuNational Cheng Kung University
Stem cell-based approaches to study neurological disordersDerek DykxhoornUniversity of Miami Miller School of Medicine
Using iPS-derived cells to produce functional human liver organoidsErnesto GoulartUniversity of São Paulo
Adipose-derived stem cells as a cell source for cultivated meat productionPetra HangaUniversity College London
Artificial cells: From therapy to regenerationMahdi HasaniUniversity of California Los Angeles
Human induced pluripotent stem cells: Applications in neurodevelopmental and neurodegenerative diseasesYoussef HibaouiUniversity Hospital of Fribourg
De-risking preclinical drug development: simultaneous assessment of efficacy and toxicityJames Keck**The Jackson Laboratory
Characterizing stems cells using Invitrogen antibodiesJamuna KSThermo Fisher Scientific
Understanding and modifying cellular age-stageChristian Nefzger**University Queensland
Cell and gene therapiesJan Nolta**University of California Davis Health
Accelerating the future of stem cell research with connected automationSean Peschisolido & Sarah YesfordThermo Fisher Scientific
The growing concern of off-target effects: How to measure and minimize off-target effects in your genome editing experimentsPandhita PochanardThermo Fisher Scientific
Simplified online tools for CRISPR-Cas9 gene editing design and confirmationMatt PolingThermo Fisher Scientific
In vitro characterization of mesenchymal stromal cells: Promising uses in spinal cord injuryCarolina Quintero GilBioxcellerator
Challenges & hurdles for clinical application of iPSC in South KoreaYeri Alice RimCatholic iPSC Research Center (CiRC)
Placental susceptibility to SARS-CoV-2 and its physiological impact on mesenchymal stem cellsMairim SolisSistema Nacional de Investigación de Panamá
Advanced stem cell therapies for patients with kidney diseaseCathelijne van den BergLeiden University Medical Center
The importance of quality control assays for pluripotent stem cell line banksErik WillemsThermo Fisher Scientific
Stem cells and genomics for precision cardiovascular medicineJoseph Wu**Stanford Cardiovascular Institute
Forming hearts and repairing hearts with hPSCsRobert Zweigerdt**Hannover Medical School
**Keynote presenter


Rotea: A versatile cell therapy workflow instrument for cell isolation, washing, and concentrationCarl DargitzThermo Fisher Scientific
Development of a robust and scalable culture platform for expansion and neural induction of human pluripotent stem cells in suspension cultureCláudia MirandaInstitute for Bioengineering and Biosciences (iBB), University of Lisbon
Differentiation of iPSCs in 3D: Leveraging suspension cultures for scale and efficiencyDavid KuningerThermo Fisher Scientific
Optimization and standardization in stem cell manufacturing for the fight against COVID-19Donna ChangHope Biosciences
Using iPS-derived cells to generate a functional human liver through 3D bioprintingErnesto GoulartCenter for the Study of Human Genome and Stem Cells – University of Sao Paulo
Advancing pluripotent stem cell technologies for research and therapy of blood diseasesIgor SlukvinUniversity of Wisconsin
Human iPSC-derived vascularised and innervated cardiac organoids for modelling heart diseases in a dishJarmon LeesSt Vincent's Institute of Medical Research
A high-throughput functional screen reveals human embryonic stem cell self-renewal signalsJean LuGenomics Research Center, Academia Sinica
Insulin-Producing Islets to Combat Diabetes from Stem CellsJeff MillmanWashington University School of Medicine
iPSC-based high throughout platforms for screening novel therapeutics for treatment of Alzheimer's Disease and Parkinson's DiseaseJiayin YangCell Inspire Therapeutics
Personalized cell therapy for Parkinson’s diseaseKwang-Soo KimMcLean Hospital/Harvard Medical School
Using stem cells in cartilage repair and tissue engineeringLaila MontaserMedicine Menoufia University, Egypt
In vitro models of human neurogenesisLarisa Haupt Queensland University of Technology 
A human stem cell based model for retinoblastomaLaura SteenpassTechnical University Braunschweig
Advanced tools for knock-in genome editing in iPSCsMatt Poling Thermo Fisher Scientific
Addressing the needs of 3D suspension culture systems through the optimization of a new PSC mediumMichael AkenheadThermo Fisher Scientific
Characterization of human iPSC-derived neurons by transcriptomics and proteomics for drug discoveryNaomi Okugawa & Dirk WaltherBiogen
New enabling technologies for 3D quantitative cellular biology using High-Content ScreeningNick RadioThermo Fisher Scientific
Optimizing stem cells workflows to build better disease modelsOmar FarahThermo Fisher Scientific
Tackling Glioblastoma with organoid modelsRicha SinghaniaWeill Cornell Medical Center 
Epigenetic regulation of human naïve pluripotencyRitu KumarWeill Cornell Medicine
Transitioning from discovery and development to manufacturing - Challenges and opportunitiesRupa PikeThermo Fisher Scientific
Adipose-derived stem cells for skin regenerationSilvia E. Castro Piedra & Johan Morales SanchezBiotechnology Research Center, Costa Rica Institute of Technology
Human stem cell derived cardiomyocytes for healthcare translation: compound screening and tissue engineeringSoong Poh LoongNational University of Singapore Ternion Biosciences        
Modelling disorders of the brain through patient-derived stem cellsThomas DurcanMNI, McGill University
Understanding human pluripotent states and their applicationsThor Theunissen Washington University School of Medicine
Human iPSC-based disease modeling and therapeutic developmentYanhong Shi City of Hope
Molecular dynamics associated with development of human GABAergic interneuronsZhexing WenEmory University School of Medicine


Turning human pluripotent stem cells into highly-pure and engraftable tissue progenitorsLay Teng AngStanford University School of Medicine
Survival of the Fittest: The Cause and Consequences of Genetic Changes in Human Pluripotent Stem CellsIvana BarbaricUniversity of Sheffield
CTS StemPro HSC Expansion Medium for Cell and Gene TherapiesAbigail BeckerThermo Fisher Scientific
Parkinson’s Disease in a Petri Dish: Harnessing iPSCs to develop an improved model of Personalized MedicineIndrani DattaNational Institute of Mental Health and Neuro Sciences
Organoids, Spheroids, and 3D Cell Culture Models, Oh My!: Using advanced cell culture models, tissue clearing, and high content confocal microscopy to get the most of your in vitro studiesErin EdwardsVisikol, Inc.
Manufacturing pluripotent cell therapeutics: the importance of quality from the very beginningBen FryerPluristyx, Inc.
3D Neural Organoid Formation from iPSCsEdwin GolezThermo Fisher Scientific
Cancer Spheroid Formation Using Nunclon Sphera MicroplatesEdwin GolezThermo Fisher Scientific
GMP Ancillary Materials for Cell and Gene Therapy Manufacturing: What to consider and when to make the switchKasey Kime & Eric Roos Thermo Fisher Scientific
Designing the genome editing strategies for stem cellsSanjay KumarThermo Fisher Scientific
Characterization assays for human iPSCRex LacambacalThermo Fisher Scientific
Circulating Mesenchymal Stem Cells in Bone HealingGang LiThe Chinese University of Hong Kong
The basics of stem cell biology and a spot light on perinatal stem cellsRebecca LimMonash University
Focus on stem cell quality: Improving rigor and reproducibility through characterizationTennielle Ludwig & Erik McIntireWiCell Research Institute
iPSC Generation, Culture and Banking in 2019: What do I need to know to start my iPSC project todayGustavo MostoslavskyBoston University School of Medicine
Characterization of multiple phenotypes in individuals with idiopathic autism using high-throughput screening of hiPSC-derived cortical organoidsMichael NestorHussman Institute for Autism
Using iPSCs and Cerebral organoids to dissect the pathophysiology of brain growth disordersFilomena PirozziSeattle's Children Research Institute
Gene editing in hematopoietic stem cells: tools for tracking, studying gene function, disease modeling, and potential promise for gene therapyJason PotterThermo Fisher Scientific
Human Pluripotent Stem Cells-Derived 3D HepatospheresHassan RashidiUCL Great Ormond Street Institute of Child Health
Characterization of Independent Clones of Human Induced Pluripotent Stem Cell-line-NCCSi005 derived from Control Individual of Indian EthnicityAnjali Shiras National Centre for Cell Science, Pune
Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic CancerHervé Tiriac University of California - San Diego
Single Cell Sorting of Genome Edited iPSC Cell PoolsGarrett WongThermo Fisher Scientific
Exosomes and beyond: translation of small molecules and cellular organellesPhil YangStanford University School of Medicine
Using human pluripotent stem cells as platform for studying diseases and drug discoveryTing Zhou Memorial Sloan Kettering  


Efficient generation of pancreatic β cell precursors from human pluripotent stem cellsEssam AbdelalimDiabetes Research Center - QBRI College of Science and Engineering, HBKU
GMP Ancillary Materials for Cell and Gene Therapy Manufacturing: What to consider and when to make the switchJoanna Asprer
Lauren Sangenario
Thermo Fisher Scientific
Thermo Scientific Cell Locker System Segregates Stem Cells, Protecting from Contamination and Enhancing Environmental StabilityMaryKay BatesThermo Fisher Scientific
Autologous iPS Cell Therapy for Macular Degeneration: From Bench-To-Bedside Kapil BhartiNational Eye Institute National Center for Advancing Translational Sciences, National Institutes of Health
Strategies for Successful Grant ProposalsDevon BrewerScience Docs
Embryonic Stem (ES) Cell FBS QualifiedCarl DargitzThermo Fisher Scientific
Pluripotent stem cell pickingCarl DargitzThermo Fisher Scientific
Differentiating neuronsJordan DizonThermo Fisher Scientific
Biotechnology Entrepreneurship Phil GreenwoodUniversity of Wisconsin-Madison
Undiagnosed disease to rare disease discovery: Perspectives from a patient familyGay GrossmanADCY5.org
Human PSC-based disease modeling to study X-linked Dystonia-ParkinsonismWilliam HendriksHarvard Medical School
Dept. of Neurology, Mass Gen Hospital
Generation and application of 3D-organoid cell culture models using human induced pluripotent stem cells (iPSCs) for drug discoveryRyan Hicks**AstraZeneca
Improved Neuronal Performance with the Gibco B-27 Plus Culture SystemDavid KuningerThermo Fisher Scientific
Build Your Personal BrandJoe LaPointeThermo Fisher Scientific
Molecular methods to QC cells intended for translationJeanne LoringThe Scripps Research Institute
Routine passagingChad MacArthurThermo Fisher Scientific
Towards commercial manufacture of pluripotent stem cell derived therapiesRhys Macown**Cell and Gene Therapy Catapult
Disease modelling with human pluripotent stem cells: general principles and specific applications to obesity variants in human pluripotent stem cellsFlorian MerkleUniversity of Cambridge
Applications of Brain-Model TechnologyAlysson Muotri**University of California, San Diego
Human stem cells for modelling neurological disease and its therapeutic applicationsRakhi PalCentre for Brain development and Repair, Instem, Bangalore
Beyond Automated iPSC reprogramming: applications for a fully automated cell culture system for pluripotent stem cell researchDaniel PaullThe New York Stem Cell Foundation Research Institute
Reprogrammed stem cells to study psychedelic substancesStevens RehenD'Or Institute for Research and Education (IDOR) & Institute of Biomedical Sciences Federal University of Rio de Janeiro
Use of stem-cell derived endothelial cells for disease relevant cell modeling and drug discoveryFilip Roudnicky**Roche 
Precise Gene Editing of Human Pluripotent Stem CellsKris Saha**University of Wisconsin-Madison
Using human stem cells to model neocortical gyration phenotypesAshleigh Schaffer**Department of Genetics and Genome Sciences, Case Western Reserve University
Addressing the scalability of human iPSC-derived neurons for HTS implementation and phenotypic screeningBanuPriya SridharanThe Scripps Research Institute-Florida
A gut feeling about stem cell therapy for enteric neuropathiesLincon StampUniversity of Melbourne
Modeling Inflammation And Fibrosis In Humans with PSC-derived Steatohepatitis Liver OrganoidsTakanori Takebe**Cincinnati Children’s Hospital Tokyo Medical and Dental University Yokohama City University
Accelerating cures for rare childhood diseases by building global patient communities and iPSC collectionsChristina WatersRARE Science Inc Global Rare Disease Program, WuXi NextCODE
Transfection using the Neon Transfection SystemJackie WebbThermo Fisher Scientific
Improvements in building in vitro pluripotent stem cell-derived disease modelsErik WillemsThermo Fisher Scientific
**Keynote presenter


Utilization of stem cells to crack motor neuron development and degenerationJun-An Chen**Institute of Molecular Biology Academia Sinica
Organoid technology—from adult stem cells to miniature organsHelmuth Gehart**Hubrecht Institute for Developmental Biology and Stem Cell Research
Mammalian DNA methylation landscapes and human cancersAlexander Meissner**Max Planck Institute for Molecular Genetics
Human pluripotent stem cells in understanding genetic cardiovascular disease and effects of drugsChristine Mummery**Leiden University Medical Center  
On the road to realizing tissue engineering’s transformative potential: multidisciplinary approach to accelerate bench-to-clinic transitionNina Tandon and Ben Shepherd**EpiBone Organovo  
Eliminating inherent genome editing bottlenecks in iPSCs to build physiologically relevant disease modelsErik Willems**Thermo Fisher Scientific
Gibco sera—driving quality and innovation in a dynamic marketMatthew Dallas and Chris Scanlon**Thermo Fisher Scientific
Industry uses of human pluripotent stem cellsStuart ChambersAmgen
Custom-tailored cardiomyocytes: Directed differentiation of human pluripotent stem cells into defined atrial and ventricular cardiomyocyte subtypesLukas CyganekUniversity of Göttingen
Comparison of the teratoma assay and in vitro surrogate tests for assessment of pluripotency of human pluripotent stem cellsChristian FreundLeiden University Medical Center
Directed differentiation of hematopoietic cells from human pluripotent stem cellsAlessandra GiorgettiCenter for Regenerative Medicine in Barcelona
Examining the negative impacts of bioflavonoids on the DNA damage response and DNA repair mechanisms in mouse embryonic stem cellsDonna GoodenowUniversity of North Carolina at Charlotte
Mechanisms for assembling and resolving naïve pluripotencyJacob HannaWeizmann Institute of Science
Pluripotent stem cell bioprocessing platforms for cell therapy manufacturingJahid HasanCell and Gene Therapy Catapult
Identification of a high titer lentiviral production alternative to facilitate regenerative medicine therapiesCalley HirschCCRM
Building inner ear organoids from human pluripotent stem cells through directed self-assemblyKarl KoehlerIndiana University School of Medicine
Integrated processes for derivation, expansion and differentiation of hiPSC to blood in IPS-Spheres™ culturesAlan LamBioprocessing Technology Institute (BTI) of Singapore
New monoclonal antibodies to defined cell surface proteins on human pluripotent stem cellsAndrew LaslettCommonwealth Industrial and Scientific Research Organisation or CSIRO
Genomic profiling reveals novel PAX7 targets CD54, integrin α9β1 and SDC2, as markers for isolation of human ES/iPS cell-derived muscle progenitorsAlessandro MagliUniversity of Minnesota
Pluripotent stem cells to explore mechanisms and treatments of neuromuscular diseasesCécile MartinatI-Stem French Stem Cell Society
iPSC-derived neural cells for drug discovery of mitochondrial brain diseases  Alessandro PrigioneMax Delbrueck Center for Molecular Medicine (MDC)
New insights about Zika virus infection using iPS cells  Stevens RehenD'Or Institute for Research and Education (IDOR) & Institute of Biomedical Sciences, Federal University of Rio de Janeiro  
Pancreatic progenitors: from the organ to the plateMeritxell RoviraCenter for Regenerative Medicine in Barcelona
Braingineering’s human midbrain organoids as novel model for neurodegenerative diseasesJens Christian SchwambornBraingineering Technologies SARL
Patient-specific hiPSCs for understanding diabetes disease mechanisms  Adrian Kee Keong TeoIMCB, A*STAR SBS and LKC Medicine, NUS Medicine
Preparing for what’s next – keys to a successful career searchSarah GibsonThermo Fisher Scientific
How to do an elevator pitch that will win you friends, admirers and maybe even fundingKevin McCormackCalifornia Institute for Regenerative Medicine
Journal publishing tools that make your research stand outRebecca ShumbataMary Ann Liebert, Inc. Publishers
How to get the most out of LinkedInAnia WronskiThermo Fisher Scientific
Physiological oxygen: historical and molecular perspective for stem cell cultureMary Kay BatesThermo Fisher Scientific
New viral and non-viral platforms for T-cell engineeringXavier de Mollerat du JeuThermo Fisher Scientific
New Gibco B-27 Plus Neuronal Culture System—next generation media  for superior  neuronal survival and functionalityNavjot KaurThermo Fisher Scientific
New tools for improved CRISPR gene-editing in stem cellsJames KehlerThermo Fisher Scientific
Highly efficient stem cell engineering via Cas9 protein transfectionXiquan LiangThermo Fisher Scientific
Comprehensive characterization of pluripotent stem cellsSuman PradhanThermo Fisher Scientific
**Keynote presenter


Genetic variability of ps-iPSC and related blood and fibroblasts—somatic mutationsSilke Rickert-Sperling**Charité Medical Faculty and the Max Delbrück Center for Molecular Medicine
Charité - Universitätsmedizin Berlin
Molecular elucidation and engineering of stem cell fate decisionsDavid Schaffer**University of California, Berkeley
Using patient-derived iPSCs to model and treat inherited retinal degenerative blindnessBudd Tucker**University of Iowa Carver College of Medicine
Optimization of your PSCs workflowJing HeThermo Fisher Scientific
Initiatives to advance stem cell science and medicine at California’s $3 billion stem cell agencyStephen LinCalifornia Institute for Regenerative Medicine
Partnering to advance regenerative medicine and cellular therapiesMorrie Ruffin
Michael Werner
Adjuvant Partners
Holland & Knight
Evolving your media system for modern stem cell applicationsRhonda NewmanThermo Fisher Scientific
From bench to BLA—a review of common regulatory questionsJoyce Frey-Vasconcells
Michael Mendicino
Kelli Tanzella
Frey-Vasconcells Consulting, LLC
Hybrid Concepts International
Thermo Fisher Scientific
Precise generation of desired human cell-types from embryonic stem cellsLay Teng AngGenome Institute of Singapore
Derivation of a spectrum of regional motor neuron phenotypes for hindbrain and spinal cord regenerative medicineRandolph AshtonUniversity of Wisconsin Madison
Directed differentiation of induced pluripotent stem cells to hepatic stellate cellsPau Sancho BruInstitut D'Investigacions Biomediques August Pi I Sunyer (IDIBAPS)
Elucidating the physiological function of cellular PrPC using human iPS cellVijay ChandrasekarUniversitat Zurich
‘HipSci' and the ‘Stem cell hotel’: innovative platforms for collaborative phenotypingDavide DanoviKing's College London
Disease modelling in pluripotent stem cell-derived cardiomyocytesChris DenningUniversity of Nottingham
Human pluripotent stem cells for the study of enteric neuropathiesFaranak FattahiMemorial Sloan-Kettering Cancer Center and Weill Cornell Medicine
Transitioning to the clinic from proof of concept research: Challenges associated with converting research materials and methods to a clinical grade product.Ben FryerUniversity of Washington School of Medicine
Human PSC-based disease modeling to study X-linked dystonia-parkinsonismWilliam HendriksHarvard Medical School
Use of stem cell models to assess genetic change underlying neurodevelopmental disordersLachlan JollyThe University of Adelaide
Building embryonic lineagesLeo KurianCECAD - Cluster of Excellence, Institute for Neurophysiology & Center for Molecular Medicine (CMMC), University of Cologne
Human umbilical cord mesenchymal cells and the treatment of bronchopulmonary dysplasiaWillie LinMeridigen Biotech Co., Ltd.
Stem cells for regeneration and rescueJeanne LoringThe Scripps Research Institute
First allogeneic mesenchymal stromal cell product approved in India for Buerger’s disease—an unmet medical needAnish Sen MajumdarStempeutics Research
Transplanted human stem cell-derived interneuron precursors mitigate mouse bladder dysfunction and central neuropathic pain after spinal cord injuryCory NicholasNeurona Therapeutics
University of California, San Francisco
Exploring new avenues for cataract treatment using human pluripotent stem cellsMichael O’ConnorWestern Sydney University
University of Sydney,
Challenge toward clinical trial for spinal cord injury using iPS cellHideyuki OkanoKeio University School of Medicine
Brain Science Institute RIKEN
Optimizing retinal cell differentiation of human pluripotent stem cells for large-scale disease modeling.Alice PébayUniversity of Melbourne
From urine to the study of metabolic disease—A patient-driven strategy to decipher PCSK9 roles and functionsKarim Si-Tayebl’institut du thorax INSERM
From millions to billions to trillions – translating your cell discovery into a cell productNick TimminsCCRM, Canada
Regulation of autologous cell clinical interventionsBernie TuchNSW Stem Cell Network
Immunomodulation and immunogenicity of human MSC-like cells: What did we learn from in vitro and in vivo studies?Hans-Dieter VolkCharité-Universitätsmedizin Berlin
Translating pluripotent stem cell therapies for focal brain disordersDustin WakemanRxGen, Inc.
Improved differentiation of human pluripotent stem cell-derived neurons through reduction of progenitor proliferation: impact on downstream applicationsDavid KuningerThermo Fisher Scientific
Analyzing stem cell populations using flow cytometryJolene BradfordThermo Fisher Scientific
Techniques and recommendations for colony selection and passage of iPSCChad MacArthurThermo Fisher Scientific
The matrix equation—solving for the best PSC culture goalsRhonda NewmanThermo Fisher Scientific
iPSC generation and validation: Ensuring the best materials for downstream applicationsRene QuintanillaThermo Fisher Scientific
Delivery solutions for robust CRISPR-based genomic editing in stem cells for disease model generation   Nektaria AndronikouThermo Fisher Scientific
**Keynote presenter


Genome editing and stem cell engineering for disease modelingJon Chesnut**Thermo Fisher Scientific
Probing disease mechanisms in ALS and ion-channel epilepsy using iPSCs, reprogramming and optogenetic approaches Evangelos Kiskinis**Northwestern University
Biomaterials for assembly of stem cell-derived human tissuesWilliam Murphy**University of Wisconsin
Epigenetic regulation in stem cells and reprogrammingAlexander MeissnerHarvard University
Harvard Stem Cell Institute
Standardizing stem cell researchAlexander Meisner Ernest Wolvetang Tennielle Ludwig 
Differentiation of midbrain floor plate progenitors and dopaminergic neurons from human pluripotent stem cellsSoojung ShinThermo Fisher Scientific
Essential 8 Flex: Eliminating daily feeding in feeder-free, xeno-free PSC culture systemMatthew DallasThermo Fisher Scientific
Antibodies for stem cell researchKara MachleditThermo Fisher Scientific
Highly efficient genome editing and cell engineering in stem cells using CRISPR/Cas9Namritha Ravinder Shantanu KumarThermo Fisher Scientific
Improved T cell function and in vivo engraftment of CAR-T cells expanded ex vivo with CTS Immune Cell SRAngel Varela RohenaThermo Fisher Scientific
Pluripotent stem cell characterization methodsDeborah TiebergThermo Fisher Scientific
Pluripotent stem cell culture systems: Identification of appropriate medium, matrix and passaging reagentRhonda NewmanThermo Fisher Scientific
PSCs to cardiomyocytes in three stepsAlex HannayThermo Fisher Scientific
Thermo Fisher Scientific’s cell therapy capabilitiesBrian NewsomThermo Fisher Scientific
Optimizing retinal cell differentiation of human pluripotent stem cells for large-scale disease modelingAlice Pébay  University of Melbourne
HOXA gene expression defines definitive fetal hematopoietic cells differentiated from human embryonic stem cellsAndrew ElefantyMurdoch Children’s Research Institute
Muscle stem cells harboring basal levels of pluripotency genes are amenable to pluripotent conversion without using reprogramming factors or small moleculesBipasha BoseYenepoya University
The use of modified mRNA to enhance the generation of induced neural precursor cells from adult human fibroblastsBronwen ConnorUniversity of Auckland
Functional dissection of disease-associated chromosomal deletions with human iPSCsEirini PapapetrouIcahn School of Medicine at Mount Sinai
Human oocyte as source of information to study cell pluripotency and reprogrammingElena González MuñozCentro Andaluz de Nanomedicina y Biotecnología (BIONAND)
Standardized generation of patient-specific iPSC lines and scalable production of PSC-derived cardiomyocytesEmily TitusCCRM, Canada
In vitro quantification of the terminal differentiation potential of pluripotent stem cellsErnst WolvetangUniversity of Queensland
A novel  PSC-based myogenic platform to explore treatment strategies for muscle diseasesJérôme ChalHarvard Medical School  
The laminin protein family—key to stem cell cultureJesper EricssonBioLamina
Variability of cardiomyocyte differentiation among human pluripotent stem cells: A practical screening approachKatherine SantostefanoUniversity of Florida Center for Cellular Reprogramming
Modeling predisposition to schizophrenia using hiPSCsKristen BrennadIcahn School of Medicine at Mount Sinai
Dental pulp of the third molar: a new source of pluripotent-like stem cellsMaher AtariUniversitat Internacional de Catalunya
Generation of induced pluripotent stem (iPS) cell-derived cardiomyocytes for disease modeling and drug discoveryNirupama PikeStem Cell Theranostics
Efficient generation of footprint-free patient-specific iPS cells and the application for drug screeningNoemi FusakiKeio University School of Medicine
Scalable xeno-free culture system for human induced pluripotent stem cellsTiago FernandesInstitute for Bioengineering and Biosciences
Tissue engineering of hiPSC for endothelial cell regeneration and cardiac repairYe LeiNational Heart Centre Singapore
Toward large-scale functional genomic studies through the automation of induced pluripotent stem cell derivation, expansion and differentiationDaniel PaullNew York Stem Cell Foundation
Modeling eye diseases using human adult retinal pigment epithelium stem cellsTimothy BlenkinsopIcahn School of Medicine at Mount Sinai
Combined stem cell transplantation and gene therapy on the regeneration of corticospinal axons after spinal cord injuryStuart HodgettsUniversity of Western Australia  
**Keynote presenter


The future of pluripotent stem cell bankingJonathan Loh Yuin-HanA*STAR Institute of Molecular and Cell Biology
Utility of gene expression signatures for the characterization of cellular identityAlexander MeissnerHarvard Stem Cell Institute
Reprogramming cells to study mental disordersStevens RehenInstitute of Biomedical Sciences, Federal University of Rio de Janeiro and D’Or Institute for Research and Education
Molecular engineering of biomaterial platforms for scalable stem cell manufacturingDavid SchafferUniversity of California at Berkeley
Using iPS cell technology to model human neurodegenerative diseasesAngel RayaCenter for Regenerative Medicine in Barcelona (CMRB)
Pluripotent stem cells to model human brain developmentChris FasanoNeural Stem Cell Institute
Scalable production of human stem/progenitor cells in bioreactor systemsClaudia Lobato da SilvaStem Cell Bioengineering and Regenerative Medicine Laboratory, Instituto Superior Técnico, Universidade de Lisboa
Deriving functional hepatocytes from pluripotent stem cellsDavid HayMRC Centre for Regenerative Medicine
Hematopoietic disease modeling using iPSCsDeborah FrenchThe Children's Hospital of Philadelphia
Development of chemically defined cell culture for human pluripotent stem cellsGuokai ChenUniversity of Macau, China
Culture adaptation of pluripotent stem cells: an in vitro model for oncogenesisIvana BarbaricUniversity of Sheffield
iPSCs for modeling disease in AfricaJanine ScholefieldCSIR Biosciences
Reversibility of the cellular aging physiology through an iPSC state : a new paradigm for human cell rejuvenationJean-Marc LemaitreInstitute of Regenerative Medicine and Biotherapies, INSERM, Stem Cell Core Facility SAFE-iPSC
Derivation and function of clinical-grade human ESCs in Parkinson's disease monkey modelsJie HaoChinese Academy of Sciences
Knock-in gene correction in pyruvate kinase deficiency patient–derived iPSC, the most common metabolic erythroid diseaseJose Carlos SegoviaCIEMAT/CIBERER
Developing autologous cell therapy for macular degeneration using IPS cell–derived RPE tissue: a model for public-private partnershipKapil BhartiNational Eye Institute, National Institutes of Health
Reprogramming somatic cells using the Sendai virus technologyLaurence DaheronHarvard Stem Cell Institute
Mechanisms of reprogramming: applying lessons from mouse models to improve the efficiency of an iPSC core facilityLaurent DavidMedical School of University of Nantes
Induced pluripotent stem cells: time for standardsMathilde GirardI-Stem
Pluripotency factors and cell lineage specificationMichael PuceatFrench National Institute of Health and Medical  Research, INSERM
The challenges and possible solutions for transferring cell therapy from the bench to the industry, while assuring high quality and manufacturing efficiencyOhad KarnieliPluristem Therapeutics Inc
SCL/TAL1-mediated transcriptional network enhances megakaryocytic specification of human embryonic stem cellsPedro RealGENYO Centre for Genomics and Oncological Research: Pfizer-University of Granada-Andalusian Regional Government
Cellular immune therapy for virus-associated human malignancies and post-transplant infectious complicationsRajiv KhannaQIMR Centre for Immunotherapy and Vaccine Development
QIMR Berghofer Medical Research Institute
Developing a human embryonic stem cell based therapy for multiple sclerosisRen-He XuUniversity of Macau
Developing a human ES cell derived dopamine neuron source for cell therapy in Parkinson's disease—from academic to translational researchStefan IrionMSKCC
Chromatin modifiers in reprogrammingTamer OnderKoç University
iPSC reprogramming from human blood using Sendai virus mediated gene transferWenli YangUniversity of Pennsylvania
Use of pluripotent stem cells to model premature aging syndromesXavier NissanCECS, I-Stem, AFM, Institute for Stem cell Therapy and Exploration of Monogenic diseases
Transcriptome profiling and stem cell-based therapiesYi SunUCLA Institute for Stem Cell Biology and Medicine
Stage-specific grafting of hESC-derived midbrain dopamine neuronsYosif GanatMSKCC
Pharmacological modulation of cell fatesYu WangChinese Academy of Sciences
Personalized disease model in dish -  Starting with Parkinson’s DiseaseJing He
Bo Peng
Thermo Fisher Scientific
Hands-free stem cell research: services to save you timeCarolyn PetterssonThermo Fisher Scientific
Cell therapy logistics—beyond the basicsDan O’DonnellThermo Fisher Scientific
Trends and considerations for cell therapy developmentEric RoosThermo Fisher Scientific
Considerations for creating a disease model for Parkinson's disease using stem cellsKurt VogelThermo Fisher Scientific
Efficient cell specific differentiation systems for iPSCMohan VemuriThermo Fisher Scientific
Antibody based tools and protocols for characterization of pluripotent stem cellsNirupama PikeThermo Fisher Scientific
Considerations for the culture of pluripotent stem cellsJennifer CreanThermo Fisher Scientific
Differentiate pluripotent stem cells to contracting cardiomyocytes in 3 easy stepsAlex HannayThermo Fisher Scientific
Eliminate serum to gain control of your T cell researchSandra KuligowskiThermo Fisher Scientific
Rapid induction of neural stem cells without the need for EB formationAlex HannayThermo Fisher Scientific
Score! A gene expression profile for your iPS linesDeborah TiebergThermo Fisher Scientific


Genome editing to generate human cellular disease modelsChad Cowan**Harvard University
Pluripotency and differentiationAlexander Meissner**Harvard University
Reprogramming human hematopoietic cells for regenerative medicineElias Zambidis**Johns Hopkins University School of Medicine
Human pluripotent stem cell-derived dopaminergic neurons for screeningXianmin ZengBuck Institute for Research and Aging; Xcell Science, Inc.
Transcriptional analysis during reprogramming at the single cell level.Jose Polo**Monash University
Hematopoietic differentiation of human pluripotent stem cellsJunfeng JiZhejiang University
iPSC-dervied NSCs from Life Technologies Gibco  Neural Induction MediumMichael Edel**Universitat de Barcelona
Using iPS cell technology to model human neurodegenerative diseasesAngel Raya**IBEC, Barcelona
iPSCs for modeling disease in AfricaJanine Scholefield**Councel for Scientific and Industrial Research (CSIR)
Parkinson’s Part I: Life Technologies and the Parkinson’s Institute collaborate to understand the molecular basis for Parkinson’s diseaseRoland LeathersThermo Fisher Scientific
Parkinson’s Part II: Generation of induced pluripotent stem cells from Parkinson’s disease fibroblastsConnie LebakkenThermo Fisher Scientific
Parkinson’s Part III: Generation and characterization of neural stem cells from Parkinson’s disease donor-derived iPSCsKun BiThermo Fisher Scientific
Parkinson’s Part IV: Genome Editing of Parkinson’s Disease iPSCs Using GeneArtPrecision TAL TechnologySpencer HermansonThermo Fisher Scientific
Considerations for culturing neural stem cellsYiping Ya, Soojung ShinThermo Fisher Scientific
Considerations for culturing mesenchymal stem cellsShayne BoucherThermo Fisher Scientific
Considerations for culturing pluripotent stem cellsMarian PiekarczykThermo Fisher Scientific
Considerations for reprogramming pluripotent stem cellsChad MacArthurThermo Fisher Scientific
Considerations for characterizing pluripotent stem cellsRene QuintanillaThermo Fisher Scientific
CytoTune-iPS Sendai 2.0 Reprogramming KitJennifer CreanThermo Fisher Scientific
TaqMan hPSC Scorecard Panel and data analysis softwareDeborah TiebergThermo Fisher Scientific
Essential 8 media and vitronectinJames LovgrenThermo Fisher Scientific
Cell Model Services for stem cell researchCarolyn PetterssonThermo Fisher Scientific
Products and services for neural differentiationAlex HannayThermo Fisher Scientific
Genome editing tools—GeneArt TALs & CRISPRsFarzad HaerizadehThermo Fisher Scientific
**Keynote presenter
*Thermo Fisher Scientific and its affiliates are not endorsing, recommending, or promoting any use or application of products presented by third parties during this event.  Information and materials presented or provided by third parties are provided as-is and without warranty of any kind, including regarding intellectual property rights and reported results.  Parties presenting images, text, and materials represent they have the right to do so.

For Research Use Only. Not for use in diagnostic procedures.